Safety and efficacy of generic drugs with respect to brand formulation
Luca Gallelli1★, Caterina Palleria2, Antonio Vuono3, Laura Mumoli3, Piero Vasapollo3, Brunella Piro3, Emilio Russo3★ Corresponding author
- 1Department of Health Science, Regional Center on drug information, Mater Domini University Hospital, Italy and Chair of Pharmacology, School of Medicine, University of Catanzaro, Italy.
- 2Department of General Medicine, ASP Cosenza, Italy.
- 3Department of Pharmacovigilance, ASP Cosenza, Italy.
CORRESPONDENCE
Luca Gallelli
Department of Health Science, Regional Center on drug information, Mater Domini University Hospital, Italy and Chair of Pharmacology, School of Medicine, University of Catanzaro, Italy.
Volume 4, Issue 4S · pp. S110–S111 · PUBLISHED 2013 · DOI: 10.4103/0976-500X.120972
ABSTRACT
Generic drugs are equivalent to the brand formulation if they have the same active substance, the same pharmaceutical form and the same therapeutic indications and a similar bioequivalence respect to the reference medicinal product. The use of generic drugs is indicated from many countries in order to reduce medication price. However some points, such as bioequivalence and the role of excipients, may be clarified regarding the clinical efficacy and safety during the switch from brand to generic formulations. In conclusion, the use of generic drugs could be related with an increased days of disease (time to relapse) or might lead to a therapeutic failure; on the other hand, a higher drug concentration might expose patients to an increased risk of dose-dependent side-effects.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Gallelli, L., Palleria, C., Vuono, A., Mumoli, L., Vasapollo, P., Piro, B., & Russo, E. (2013). Safety and efficacy of generic drugs with respect to brand formulation. Journal of Pharmacology and Pharmacotherapeutics, 4(4S), S110–S111. https://doi.org/10.4103/0976-500X.120972